2018-2025 Dengue Vaccines Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 120 pages | ID: 2EE244894EBQEN
QYResearch

Abstracts

SUMMARY

This report studies the Dengue Vaccines market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Dengue Vaccines market by product type and application/end industries.

The global Dengue Vaccines market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Dengue Vaccines.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Dengue Vaccines in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Sanofi
• Takeda Pharmaceutical

On the basis of product, the market is primarily split into

• CYD-TDV
• Tak-003
• Other

On the basis on the end users/application, this report covers

• Hospitals
• Government Institutes
• Non-Governmental Organizations (NGOs)

Contents

2018-2025 DENGUE VACCINES REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 DENGUE VACCINES MARKET OVERVIEW

2.1 Dengue Vaccines Product Overview
2.2 Dengue Vaccines Market Segment by Type
  2.2.1 CYD-TDV
  2.2.2 Tak-003
  2.2.3 Other
2.3 Global Dengue Vaccines Product Segment by Type
  2.3.1 Global Dengue Vaccines Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Dengue Vaccines Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Dengue Vaccines Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Dengue Vaccines Price (USD/Pcs) by Type (2013-2018)
2.4 United States Dengue Vaccines Product Segment by Type
  2.4.1 United States Dengue Vaccines Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Dengue Vaccines Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Dengue Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Dengue Vaccines Price (USD/Pcs) by Type (2013-2018)

3 DENGUE VACCINES APPLICATION/END USERS

3.1 Dengue Vaccines Segment by Application/End Users
  3.1.1 Hospitals
  3.1.2 Government Institutes
  3.1.3 Non-Governmental Organizations (NGOs)
3.2 Global Dengue Vaccines Product Segment by Application
  3.2.1 Global Dengue Vaccines Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Dengue Vaccines Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Dengue Vaccines Product Segment by Application
  3.3.1 United States Dengue Vaccines Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Dengue Vaccines Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 DENGUE VACCINES MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Dengue Vaccines Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Dengue Vaccines Sales and Revenue by Regions
  4.2.1 Global Dengue Vaccines Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Dengue Vaccines Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL DENGUE VACCINES MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Dengue Vaccines Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Dengue Vaccines Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Dengue Vaccines Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Dengue Vaccines Manufacturing Base Distribution, Sales Area, Product Types
5.5 Dengue Vaccines Market Competitive Situation and Trends
  5.5.1 Dengue Vaccines Market Concentration Rate
  5.5.2 Global Dengue Vaccines Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES DENGUE VACCINES MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Dengue Vaccines Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Dengue Vaccines Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Dengue Vaccines Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Dengue Vaccines Market Share (%) of Top 3 and Top 5 Players

7 DENGUE VACCINES PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Sanofi
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Dengue Vaccines Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Sanofi Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Takeda Pharmaceutical
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Dengue Vaccines Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Takeda Pharmaceutical Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview

8 DENGUE VACCINES MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Dengue Vaccines Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Dengue Vaccines Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL DENGUE VACCINES MARKET FORECAST

10.1 Global Dengue Vaccines Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.1 Global Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Dengue Vaccines Market Forecast
  10.2.1 United States Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Dengue Vaccines Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Dengue Vaccines Forecast by Regions
  10.3.1 North America Dengue Vaccines Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Dengue Vaccines Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Dengue Vaccines Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Dengue Vaccines Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Dengue Vaccines Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Dengue Vaccines Forecast by Type
  10.4.1 Global Dengue Vaccines Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Dengue Vaccines Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Dengue Vaccines Forecast by Application
  10.5.1 Global Dengue Vaccines Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Dengue Vaccines Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Dengue Vaccines Product Picture
Figure Global Dengue Vaccines Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Dengue Vaccines Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of CYD-TDV
Table Major Players of CYD-TDV
Figure Global CYD-TDV Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Tak-003
Table Major Players of Tak-003
Figure Global Tak-003 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Other
Table Major Players of Other
Figure Global Other Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Dengue Vaccines Sales (K Pcs) by Type (2013-2018)
Table Global Dengue Vaccines Sales Share (%) by Type (2013-2018)
Figure Global Dengue Vaccines Sales Market Share (%) by Type (2013-2018)
Figure Global Dengue Vaccines Sales Market Share (%) by Type in 2017
Table Global Dengue Vaccines Revenue (Million USD) by Type (2013-2018)
Table Global Dengue Vaccines Revenue Share (%) by Type (2013-2018)
Figure Global Dengue Vaccines Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Dengue Vaccines Revenue Market Share (%) by Type
Table Global Dengue Vaccines Price (USD/Pcs) by Type (2013-2018)
Table United States Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Dengue Vaccines Sales (K Pcs) by Type (2013-2018)
Table United States Dengue Vaccines Sales Share (%) by Type (2013-2018)
Figure United States Dengue Vaccines Sales Market Share (%) by Type (2013-2018)
Figure United States Dengue Vaccines Sales Market Share (%) by Type in 2017
Table United States Dengue Vaccines Revenue (Million USD) by Type (2013-2018)
Table United States Dengue Vaccines Revenue Share (%) by Type (2013-2018)
Figure United States Dengue Vaccines Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Dengue Vaccines Revenue Market Share (%) by Type
Table United States Dengue Vaccines Price (USD/Pcs) by Type (2013-2018)
Figure Hospitals Examples
Figure Government Institutes Examples
Figure Non-Governmental Organizations (NGOs) Examples
Table Global Dengue Vaccines Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Dengue Vaccines Sales (K Pcs) by Application (2013-2018)
Table Global Dengue Vaccines Sales Share (%) by Application (2013-2018)
Figure Global Dengue Vaccines Sales Market Share (%) by Application (2013-2018)
Figure Global Dengue Vaccines Sales Market Share (%) by Application in 2017
Table United States Dengue Vaccines Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Dengue Vaccines Sales (K Pcs) by Application (2013-2018)
Table United States Dengue Vaccines Sales Share (%) by Application (2013-2018)
Figure United States Dengue Vaccines Sales Market Share (%) by Application (2013-2018)
Figure United States Dengue Vaccines Sales Market Share (%) by Application in 2017
Table Global Dengue Vaccines Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Dengue Vaccines Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Dengue Vaccines Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Dengue Vaccines Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Dengue Vaccines Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Dengue Vaccines Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Dengue Vaccines Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Dengue Vaccines Sales (K Pcs) by Regions (2013-2018)
Figure Global Dengue Vaccines Sales Market Share (%) by Regions (2013-2018)
Figure Global Dengue Vaccines Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Dengue Vaccines Sales Market Share (%) by Regions
Figure 2017 United States Dengue Vaccines Sales Market Share (%) in Global Market
Table Global Dengue Vaccines Revenue (Million USD) by Regions (2013-2018)
Table Global Dengue Vaccines Revenue Market Share (%) by Regions (2013-2018)
Figure Global Dengue Vaccines Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Dengue Vaccines Revenue Market Share (%) by Regions
Figure 2017 United States Dengue Vaccines Revenue Market Share (%) in Global Market
Table Global Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Dengue Vaccines Sales (K Pcs) of Key Players (2013-2018)
Table Global Dengue Vaccines Sales Share (%) by Players (2013-2018)
Figure 2017 Global Dengue Vaccines Sales Share (%) by Players
Figure 2018 Global Dengue Vaccines Sales Share (%) by Players
Table Global Dengue Vaccines Revenue (Million USD) by Players (2013-2018)
Table Global Dengue Vaccines Revenue Share (%) by Players (2013-2018)
Table 2017 Global Dengue Vaccines Revenue Share (%) by Players
Table 2017 Global Dengue Vaccines Revenue Share (%) by Players
Table Global Market Dengue Vaccines Average Price (USD/Pcs) by Players (2013-2018)
Table Global Dengue Vaccines Top Players Manufacturing Base Distribution and Sales Area
Table Global Dengue Vaccines Top Players Product Category
Figure Global Dengue Vaccines Market Share (%) of Top 3 Players
Figure Global Dengue Vaccines Market Share (%) of Top 5 Players
Table United States Dengue Vaccines Sales (K Pcs) by Players (2013-2018)
Table United States Dengue Vaccines Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Dengue Vaccines Sales Share (%) by Players
Figure 2018 United States Dengue Vaccines Sales Share (%) by Players
Table United States Dengue Vaccines Revenue (Million USD) by Players (2013-2018)
Table United States Dengue Vaccines Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Dengue Vaccines Revenue Share (%) by Players
Table 2017 United States Dengue Vaccines Revenue Share (%) by Players
Table United States Market Dengue Vaccines Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Dengue Vaccines Market Share (%) of Top 3 Players
Figure United States Dengue Vaccines Market Share (%) of Top 5 Players
Table Sanofi Basic Information List
Table Sanofi Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Sanofi Dengue Vaccines Sales Growth Rate (2013-2018)
Figure Sanofi Dengue Vaccines Sales Global Market Share (%)(2013-2018)
Figure Sanofi Dengue Vaccines Revenue Global Market Share (%)(2013-2018)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Takeda Pharmaceutical Dengue Vaccines Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Dengue Vaccines Sales Global Market Share (%)(2013-2018)
Figure Takeda Pharmaceutical Dengue Vaccines Revenue Global Market Share (%)(2013-2018)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dengue Vaccines
Figure Dengue Vaccines Industrial Chain Analysis
Table Major Buyers of Dengue Vaccines
Table Distributors/Traders List
Figure Global Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Dengue Vaccines Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Dengue VaccinesDengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Dengue Vaccines Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Dengue Vaccines Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Dengue Vaccines Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Dengue Vaccines Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Dengue Vaccines Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Dengue Vaccines Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Dengue Vaccines Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Dengue Vaccines Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Dengue Vaccines Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Dengue Vaccines Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Dengue Vaccines Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Dengue Vaccines Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Dengue Vaccines Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Dengue Vaccines Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Dengue Vaccines Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Dengue Vaccines Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Dengue Vaccines Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Dengue Vaccines Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Dengue Vaccines Sales Forecast by Application (2018-2025)
Table United States Dengue Vaccines Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Dengue Vaccines Sales Forecast by Application (2018-2025)